GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 92 filers reported holding GRITSTONE ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $823,747 | -30.5% | 296,312 | -13.7% | 0.01% | -37.5% |
| Q4 2022 | $1,184,551 | -60.1% | 343,348 | -70.3% | 0.01% | -65.2% |
| Q3 2022 | $2,972,000 | +413.3% | 1,156,264 | +383.4% | 0.02% | +475.0% |
| Q2 2022 | $579,000 | -17.6% | 239,174 | +40.2% | 0.00% | -20.0% |
| Q1 2022 | $703,000 | -39.1% | 170,623 | +90.0% | 0.01% | -37.5% |
| Q4 2021 | $1,155,000 | +19.1% | 89,805 | 0.0% | 0.01% | +14.3% |
| Q3 2021 | $970,000 | +16.9% | 89,805 | -1.2% | 0.01% | +16.7% |
| Q2 2021 | $830,000 | -2.0% | 90,891 | +1.2% | 0.01% | -14.3% |
| Q1 2021 | $847,000 | +43.8% | 89,805 | -40.0% | 0.01% | +40.0% |
| Q4 2020 | $589,000 | +40.9% | 149,565 | -5.3% | 0.01% | +25.0% |
| Q3 2020 | $418,000 | +186.3% | 157,860 | +617.1% | 0.00% | +100.0% |
| Q2 2020 | $146,000 | – | 22,013 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,561,150 | $6,125,178 | 3.26% |
| Redmile Group, LLC | 8,509,126 | $14,635,697 | 0.70% |
| Avidity Partners Management LP | 2,733,800 | $4,702,136 | 0.19% |
| Frazier Life Sciences Management, L.P. | 1,430,878 | $2,461,110 | 0.16% |
| Artia Global Partners LP | 95,170 | $163,692 | 0.07% |
| Worth Venture Partners, LLC | 43,772 | $75,288 | 0.04% |
| SkyOak Wealth, LLC | 60,875 | $104,705 | 0.03% |
| Point72 Asset Management, L.P. | 5,924,867 | $10,190,771 | 0.03% |
| CORNERCAP INVESTMENT COUNSEL INC | 76,811 | $132,115 | 0.02% |
| Houlihan Financial Resource Group, Ltd. | 20,000 | $38 | 0.02% |